SCHEMBL6602474

SCHEMBL6602474

COc1cc(C2=NN(C(=O)c3ccc(NC(C)=O)cc3)CCC2)ccc1S(C)(=O)=O

nearest known ligand 0.48

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.48
POLB P06746 1/20 0.48
PGR P06401 13/20 0.46
GAA P10253 1/20 0.45
MAOB P27338 1/20 0.44
SMN1; SMN2 Q16637 2/20 0.41
LMNA P02545 2/20 0.41
CYP1A2 P05177 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
MAPT P10636 1/20 0.41
ATM Q13315 1/20 0.41
HPGD P15428 1/20 0.40
PKM P14618 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6605929 0.93 ALDH1A1 (0.48) ALDH1A1POLBPGRGAAMAOB
SCHEMBL144189 0.89 ALDH1A1 (0.45) ALDH1A1POLBPGRGAAMAOB
SCHEMBL6601093 0.89 ALDH1A1 (0.45) ALDH1A1POLBPGRGAASMN1; SMN2
SCHEMBL6601921 0.89 MAOB (0.57) ALDH1A1POLBPGRGAAMAOB
SCHEMBL6600023 0.88 ALDH1A1 (0.46) ALDH1A1POLBPGRGAAMAOB
SCHEMBL6602412 0.87 ALDH1A1 (0.52) ALDH1A1POLBPGRGAAMAOB
SCHEMBL6602252 0.87 ALDH1A1 (0.47) ALDH1A1POLBPGRGAASMN1; SMN2
SCHEMBL6603127 0.86 MAPT (0.47) ALDH1A1POLBGAASMN1; SMN2LMNA
SCHEMBL6603562 0.86 ALDH1A1 (0.42) ALDH1A1POLBPGRGAASMN1; SMN2
SCHEMBL6605418 0.86 ALDH1A1 (0.42) ALDH1A1POLBPGRGAAMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0922036-B1 ARYLALKANOYL PYRIDAZINES MERCK PATENT GMBH (DE) 2004-03-24 EP disclosed
US-6479494-B1 THEY INHIBIT SELECTIVELY PHOSPHODIESTERASE IV, WHICH CAUSES AN INCREASE OF THE INTRACELLULAR CAMP LEVEL AS CAMP INHIBITS BONE DECREASING CELLS AND STIMULATES BONE INCREASING CELLS FOR TREATMENT OF OSTEOPOROSIS MERCK PATENT GESELLSCHAFT MIT BESCHRAENKTER HAFTUNG (DE) 2002-11-12 US disclosed
US-6107295-A Arylalkanoyl pyridazines MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2000-08-22 US disclosed